FSD Pharma Inc. HUGE NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score

44/100

1/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

FSD Pharma Inc. (HUGE) .

Criteria proven by this page:

VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 40/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

44/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

28/100

→ Income

✓

GROWTH

80/100

→ Income

—

INCOME

N/A

No coverage

Valuation Snapshot — HUGE

Valuation Multiples

P/E (TTM)0.0

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.00

P/S Ratio0.00

EV/EBITDA0.0

Per Share Data

EPS (TTM)$-0.47

Book Value / Share$0.00

Revenue / Share$0.00

FCF / Share$0.00

Yields & Fair Value

Earnings YieldN/A

Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2015	$-0.01	$0.00	$-32.8K	-
2016	$0.00	$0.00	$-29.63K	-
2017	$-0.43	$20.63K	$-2.8M	-13586%
2018	$-2.82	$65.17K	$-16.67M	-25585.9%
2019	$-5.68	$196.82K	$-40.05M	-20350.3%
2020	$-2.72	$0.00	$-32.72M	-
2021	$-1.01	$0.00	$-35.41M	-
2022	$-0.60	$0.00	$-23.32M	-
2023	$-0.47	$0.00	$-18.56M	-